California Cipro Purchasers' Settlement With Bayer Over Pay-For-Delay Is Approved

California Cipro Purchasers' Settlement With Bayer Over Pay-For-Delay Is Approved

SAN DIEGO - A judge in California on Nov. 15 granted final approval to a $74 million cash settlement between Bayer Corp. and Bayer AG (collectively, Bayer) and California purchasers of the antibiotic Cipro and third-party payers who reimbursed for California purchases of Cipro on claims that Bayer paid drug companies nearly $400 million to drop challenges to Bayer's Cipro patent and to refrain from selling generic versions of the drug (Cipro Cases I and II $(All Actions$), Judicial Council Coordination Proceeding Nos. 4154 and 4220, Calif. Super., San Diego Co.).

Find full version on lexis Advance®
Access this news story on lexis.com®